
Theragen Bio is a global genome analysis service and platform-based new drug development company. They offer genome analysis services to over 700 medical institutions in Korea and research institutions in over 40 countries worldwide. The company specializes in developing next-generation personalized cancer drugs (NeoAntigen) and aims to realize personalized medicine through genome technology, providing true hope and practical solutions for human welfare and health. They are actively involved in R&D, including AI-based new drug development and cancer vaccine and drug development based on genomic precision medicine.

Theragen Bio is a global genome analysis service and platform-based new drug development company. They offer genome analysis services to over 700 medical institutions in Korea and research institutions in over 40 countries worldwide. The company specializes in developing next-generation personalized cancer drugs (NeoAntigen) and aims to realize personalized medicine through genome technology, providing true hope and practical solutions for human welfare and health. They are actively involved in R&D, including AI-based new drug development and cancer vaccine and drug development based on genomic precision medicine.